Peter N. Johnson, Pharm.D., BCPPS, FPPAG, FCCM, FASHP

---

Summary

• President's Associate Presidential Professor
• Director, PGY2 Pediatric Pharmacy Residency
• Director, Pediatric Pharmacotherapy Degree Option

---

Publications & Presentations

96. Lammers E M, Johnson P N, Ernst K D, Hagemann T M, Lawrence S M, Williams P K, Anderson M, Miller J L. Association of fentanyl with neurodevelopmental outcomes in very-low-birth-weight infants. The Annals of pharmacotherapy. 2014; 48 : 335-42

97. Johnson P N, Miller J L, Hagemann T M, Castro C, Harrison D. External validation of the medication taper complexity score for methadone tapers in children with opioid abstinence syndrome. The Annals of pharmacotherapy. 2014; 48 : 187-95

98. Miller J L, Schaefer J, Tam M, Johnson P N. Ethacrynic acid continuous infusions in critically-ill pediatric patients. Journal of Pediatric Pharmacology and Therapeutics. 2014; 18 : 167

99. Johnson P N, Benefield E C, Bui P N, Marlar R A, Gessouroun M R. Fondaparinux in an obese child with heparin-induced thrombocytopenia and a history of renal failure. Journal of Pediatric Pharmacology and Therapeutics. 2013; 18 : 303-310

100. Johnson P N, Benefield E C, Bui P N, Gausman J N, Marlar R A, Gessouroun M R. Fondaparinux monitoring: Need for a local fondaparinux-calibrated anti-factor Xa assay. Journal of Pediatric Pharmacology and Therapeutics. 2013; 18

Grants

1. Evaluation of caffeine dosing regimens and the impact of developmental pharmacokinetics in neonates with apnea of prematurity. Misc Non-Federal. Start Date: 2020. End Date: 2021.

2. Characterization of fentanyl metabolic and renal elimination pathways in children less than two years of age. Misc Non-Federal. Start Date: 2018. End Date: 2020.

3. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.

4. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.

5. Comparison of amikacin pharmacokinetics in neonates pre- and post- a dosing protocol change. Misc Non-Federal. Start Date: 2014. End Date: 2015.

Awards and Honors

1. Oklahoma Society of Health-System Pharmacists/Oklahoma Pharmacy Residency Research Conference. Oklahoma Residency Research Excellence Award (served as mentor for Dom Ropp). Date: 2023.


2. Oklahoma Society of Health-System Pharmacists/Oklahoma Pharmacy Residency Research Conference. Oklahoma Residency Research Excellence Award (served as mentor for Eugenie Chang). Date: 2023.


3. Society of Critical Care Medicine Presidential Citation. Date: 2022.


4. Oklahoma Foundation for Excellence. Oklahoma Medal for Excellence Finalist in Teaching and Administration. Date: 2022.


5. University of Oklahoma College of Medicine--Department of Pediatrics. Mentor award (for Caitlyn Bradford, PharmD). Date: 2022.

Education

1. Degree: PGY2 Pediatric Pharmacy Residency. Kentucky Children's Hospital and University of Kentucky Chandler Medical Center. Date: 2006.


2. Degree: PGY1 Pharmacy Residency. University of Kentucky Chandler Medical Center. Date: 2005.


3. Degree: PharmD. University of Mississippi School of Pharmacy. Date: 2004.


4. Degree: BS. University of Mississippi School of Pharmacy. Date: 2002.

Administrative Assignments

no results